Back to India CDSCO Services

IVD Clinical Performance Evaluations
(Forms MD-24, MD-25)

Navigate the mandatory Clinical Performance Evaluation (CPE) requirements for introducing innovative In Vitro Diagnostic (IVD) devices to the Indian market.

Consult Our CDSCO ExpertsIVD Clinical Performance Evaluations  (Forms MD-24, MD-25)

What Are Forms MD-24 & MD-25?

For manufacturers, importers, and CROs, conducting a Clinical Performance Evaluation (CPE) is a non-negotiable step in gaining regulatory approval for new IVDs. This rigorous evaluation ensures the diagnostic accuracy, reliability, and safety of the device when analyzing human samples.

Form MD-24: Application

The comprehensive application submitted via the Sugam portal. It details the proposed CPE plan, device specifications, and pre-existing in-house performance data.

Form MD-25: Permission

The official CDSCO authorization. Valid for 2 years, it grants legal permission to initiate the study based on the approved ethical and scientific plan.


The CPE Submission Process

1

Develop the Evaluation Plan (PEP)

Create a meticulous PEP detailing study design, sample collection protocols, and statistical analysis plans.

2

Obtain Ethical Committee (EC) Approval

The PEP must pass rigorous review by a CDSCO-registered independent Ethics Committee to ensure subject welfare.

3

Site & Investigator Selection

Identify qualified clinical laboratories and lead investigators equipped with the necessary expertise.

4

Compile Device Information

Gather technical specifications, in-house analytical data (sensitivity/specificity), and comprehensive risk assessments.

5

CDSCO Sugam Submission

Submit Form MD-24 electronically with all supporting dossier files via the official portal.

6

Regulatory Review & Grant

Following expert review (typically 1-2 months), CDSCO grants the MD-25 permission, obligating the study to commence within one year.

Expert CPE Support

Navigating IVD performance evaluation requirements demands deep scientific and regulatory fluency. We streamline the process from protocol design to final approval.

  • Evaluation protocol review & optimization
  • Meticulous MD-24 dossier compilation
  • EC submission support
  • Proactive CDSCO query management
Consult Our Team